Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Class A Common stock, par value $0.0001 per share
-
Shares outstanding
-
22,440,632
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
16,718,029
-
Shares change
-
+8,602,159
-
Total reported value, excl. options
-
$63,496,120
-
Value change
-
+$43,835,866
-
Put/Call ratio
-
4.4%
-
Number of buys
-
10
-
Number of sells
-
-11
-
Price
-
$5.12
Significant Holders of Celularity Inc - Class A Common stock, par value $0.0001 per share (CELU) as of Q4 2021
43 filings reported holding CELU - Celularity Inc - Class A Common stock, par value $0.0001 per share as of Q4 2021.
Celularity Inc - Class A Common stock, par value $0.0001 per share (CELU) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,718,029 shares
of 22,440,632 outstanding shares and own 74.5% of the company stock.
Largest 10 shareholders include STARR INTERNATIONAL CO INC (8,640,695 shares), C V STARR & CO INC (4,320,347 shares), Palantir Technologies Inc. (1,863,240 shares), Louis-Dreyfus Family Office LLC (720,040 shares), FMR LLC (644,600 shares), HRT FINANCIAL LP (103,365 shares), GEODE CAPITAL MANAGEMENT, LLC (70,511 shares), Lombard Odier Asset Management (USA) Corp (60,000 shares), MORGAN STANLEY (50,027 shares), and Verition Fund Management LLC (50,000 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.